Repligen
RGEN
190 hedge funds and large institutions have $1.4B invested in Repligen in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 83 increasing their positions, 54 reducing their positions, and 30 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 54
5% less funds holding
Funds holding: 199 → 190 (-9)
5% less capital invested
Capital invested by funds: $1.47B → $1.4B (-$78.5M)
6.88% less ownership
Funds ownership: 104.44% → 97.56% (-6.9%)
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
29% less call options, than puts
Call options by funds: $5.76M | Put options by funds: $8.1M
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.7M |
| 2 |
BlackRock
New York
|
+$18.6M |
| 3 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$8.17M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$13.3M |
| 2 |
PC
PointState Capital
New York
|
-$12M |
| 3 |
SCM
Sandler Capital Management
New York
|
-$9.16M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$8.64M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$7.76M |
RGEN Hedge Fund Activity: Q3 2017 in Review
190 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q3 2017, worth a combined $1.4B — down 5.3% from $1.47B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of RGEN and 25 opened new positions — a net loss of 5 holders — while 54 trimmed existing stakes and 83 added.
The largest buyer was Vanguard Group, adding an estimated $35.7M. The largest seller was Marshall Wace North America, cutting an estimated $13.3M.
- 190 institutional investors held Repligen (RGEN) as of Q3 2017, down from 199 in Q2 2017.
- Funds reported $1.4B of Repligen stock for Q3 2017, down 5.3% quarter-over-quarter.
- 25 funds opened new Repligen positions in Q3 2017 and 30 closed out, a net change of -5 holders.
- The largest Repligen buyer in Q3 2017 was Vanguard Group, an estimated $35.7M added.
- The largest Repligen seller in Q3 2017 was Marshall Wace North America, an estimated $13.3M sold.
Based on aggregated 13F filings for Q3 2017.